{"id":817470,"date":"2025-02-25T08:10:05","date_gmt":"2025-02-25T13:10:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\/"},"modified":"2025-02-25T08:10:05","modified_gmt":"2025-02-25T13:10:05","slug":"legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\/","title":{"rendered":"Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SOMERSET, N.J., Feb.  25, 2025  (GLOBE NEWSWIRE) &#8212; Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Tuesday, March 11, 2025, to review fourth-quarter and full-year 2024 results.<\/p>\n<p>During the webcast and conference call, senior leaders will provide an overview of Legend Biotech\u2019s quarter and fiscal year performance.<\/p>\n<p>Investors and other interested parties may join the live audio webcast of the call via this <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Pr5onCqZb4anCJg6fPHKgkWGKBEUycDZ9cruxO2hDLRT9yU_I8OD1Roos4A8Y_fvLfNzD8R54c03jm4iARe3dTUHGX3MERKFBZnpKdLn1ww=\" rel=\"nofollow\" target=\"_blank\">weblink<\/a>.<\/p>\n<p>A replay version of the webcast and earnings news release will be available through the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=N2O_DSfnxJrcENWjwrmFIsvsbdSy04eDCCHLPU4GOK9yzNvvzhGNns4zfbiTW7zEPiVBVoxlylqoWCMQ3rv6eN1x6mTobChLeE6bFQr-Ve0=\" rel=\"nofollow\" target=\"_blank\">Investor Relations<\/a> section of Legend Biotech\u2019s website under the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rUy86LfZYHqqIfw2M5KQmepLamOkDzoLXv5SPMqdoU8gcWrFROamDKnqA5EGUNYvFZDBxLvZ3eGGORCjYWyXDxbZhmM4rFI8jRlEKZT6uZfMhkFZzmE5-qdpM_HaLbXFgZpOEiC206pTlteoB9T1NQ==\" rel=\"nofollow\" target=\"_blank\">Events and Presentation<\/a> section approximately two hours after the call concludes.<\/p>\n<p align=\"justify\">\n        <strong>ABOUT\u00a0LEGEND BIOTECH<\/strong>\n      <\/p>\n<p align=\"justify\">With over 2,500 employees, Legend Biotech is the largest standalone cell therapy company and a pioneer in treatments that change cancer care forever. The company is at the forefront of the CAR-T cell therapy revolution with CARVYKTI<sup>\u00ae<\/sup>, a one-time treatment for relapsed or refractory\u00a0multiple myeloma, which it develops and markets with collaborator Johnson &amp; Johnson. Centered in the US, Legend is building an end-to-end cell therapy company by expanding its leadership to maximize CARVYKTI\u2019s patient access and therapeutic potential. From this platform, the company plans to drive future innovation across its pipeline of cutting-edge cell therapy modalities.<\/p>\n<p align=\"justify\">Learn more at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kQ-qXYCKp36O3ISHmg8vYShV6RYF-C6YkNZQrszJqAZ_6OmK9Tsd-Vw9Zzk29BL-rm4-24zuqHAx0N2ZbA-zg9NbCqHNsQsL88sbiPFtdgY=\" rel=\"nofollow\" target=\"_blank\">www.legendbiotech.com<\/a> and follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0hnuVwoG3GAEd51HMb1x9EQE-QqOkAMuLyPBu0pgTlpnbhnrPRK3QGcAICBlBJM2nW8DwbG2TE3Zwbe5wo_zaUZAFUUV73K_8e6ub_jd9bY=\" rel=\"nofollow\" target=\"_blank\">X (formerly Twitter)<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vAJHq3Z0CnaT74V-DhWNjjZZEVu7bB8Q7t0mD0eDGluVzSVrvDxaDeWvPGKCYfqAnmQF_ZrfIC9zn_RemjKDCAQMYlJYDJp3rel4zy9cXx8eWvxotlFJPDKLcwc4ovFRjhJ97UPwPomAUNtAcDGpsQ==\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>INVESTOR CONTACT:<\/strong>\n      <\/p>\n<p>Caroline Paul<br \/>Tel: (973) 650-5832 <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=E3MzFg2EvTxSii37Ef3SxjuOLCoyWGhRoq0G5YjSY07eovzDCoeqECps7LvJM16XLXjX4HBCASDl2f4ZyU543KSeyHzimcpoINoRzuzQfyJ8NWpHYudGc_cNf4WlPHUi\" rel=\"nofollow\" target=\"_blank\">caroline.paul@legendbiotech.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>PRESS CONTACT:<\/strong><br \/>\n        <br \/>Mary Ann Ondish<br \/>Tel: (914) 552-4625<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=p-5_ztUkrawR_1LH2bjyJd5OMROX9PiV34mnYvmJyp0lxVRKisXhH3aPb89EWxyIA5Cvsdk-koV2HrgO7c2OGGGwgZP538-hIr5nQOut3x8=\" rel=\"nofollow\" target=\"_blank\">media@legendbiotech.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4MzczMCM2Nzc2MDU2IzIxOTQ5NTI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDQ4MGJhYWEtOGYzMi00N2ZjLWJmM2ItODQ4MmFhNWNkYjY1LTEyMDY1MDU=\/tiny\/Legend-Biotech-USA-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOMERSET, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) &#8212; Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Tuesday, March 11, 2025, to review fourth-quarter and full-year 2024 results. During the webcast and conference call, senior leaders will provide an overview of Legend Biotech\u2019s quarter and fiscal year performance. Investors and other interested parties may join the live audio webcast of the call via this weblink. A replay version of the webcast and earnings news release will be available through the Investor Relations section of Legend Biotech\u2019s website under the Events and Presentation section approximately two hours after the call concludes. ABOUT\u00a0LEGEND BIOTECH With over &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-817470","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOMERSET, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) &#8212; Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Tuesday, March 11, 2025, to review fourth-quarter and full-year 2024 results. During the webcast and conference call, senior leaders will provide an overview of Legend Biotech\u2019s quarter and fiscal year performance. Investors and other interested parties may join the live audio webcast of the call via this weblink. A replay version of the webcast and earnings news release will be available through the Investor Relations section of Legend Biotech\u2019s website under the Events and Presentation section approximately two hours after the call concludes. ABOUT\u00a0LEGEND BIOTECH With over &hellip; Continue reading &quot;Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-25T13:10:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4MzczMCM2Nzc2MDU2IzIxOTQ5NTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results\",\"datePublished\":\"2025-02-25T13:10:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\\\/\"},\"wordCount\":261,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4MzczMCM2Nzc2MDU2IzIxOTQ5NTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\\\/\",\"name\":\"Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4MzczMCM2Nzc2MDU2IzIxOTQ5NTI=\",\"datePublished\":\"2025-02-25T13:10:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4MzczMCM2Nzc2MDU2IzIxOTQ5NTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4MzczMCM2Nzc2MDU2IzIxOTQ5NTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\/","og_locale":"en_US","og_type":"article","og_title":"Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results - Market Newsdesk","og_description":"SOMERSET, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) &#8212; Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Tuesday, March 11, 2025, to review fourth-quarter and full-year 2024 results. During the webcast and conference call, senior leaders will provide an overview of Legend Biotech\u2019s quarter and fiscal year performance. Investors and other interested parties may join the live audio webcast of the call via this weblink. A replay version of the webcast and earnings news release will be available through the Investor Relations section of Legend Biotech\u2019s website under the Events and Presentation section approximately two hours after the call concludes. ABOUT\u00a0LEGEND BIOTECH With over &hellip; Continue reading \"Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-25T13:10:05+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4MzczMCM2Nzc2MDU2IzIxOTQ5NTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results","datePublished":"2025-02-25T13:10:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\/"},"wordCount":261,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4MzczMCM2Nzc2MDU2IzIxOTQ5NTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\/","name":"Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4MzczMCM2Nzc2MDU2IzIxOTQ5NTI=","datePublished":"2025-02-25T13:10:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4MzczMCM2Nzc2MDU2IzIxOTQ5NTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4MzczMCM2Nzc2MDU2IzIxOTQ5NTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year-2024-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/817470","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=817470"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/817470\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=817470"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=817470"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=817470"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}